Agenus reported $-54027000 in Operating Profit for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
AstraZeneca AZN:LN -292000000 1.38B
Celldex Therapeutics CLDX:US $ -23.26M 2.92M
CSL CSL:AU $ 2.21B 1.44B
Genocea Biosciences GNCA:US $ -15.77M 118.33M
Immunogen IMGN:US $ -22.85M 11.7M
Intrexon XON:US $ -25.47M 9.8M
Jiangsu Hengrui Me. 600276:CH CH 1.85B 419.35M
Northwest Biotherapeutics NWBO:US -10697000 648K
Novartis NOVN:VX 2.56B 671M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M